Varian's Q1 Revenues Slip in Advance of Agilent Merger Completion

Varian's Q1 revenues dipped 3 percent due to lower sales volume and lower average selling prices of certain analytical instruments products, the firm said.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories